Breast Cancer Flashcards
How are pre and post-menopausal women treated differently with hormone therapies in breast cancer?
Pre-menopausal: Tamoxifen
Post-menopausal: Aromatase inhibitors
When to begin BRCA1/BRCA2 screening and what to also include?
- Should begin at 25 or five years before youngest relative diagnosed
- Should include MRI and mammogram alternating
A patient with early breast cancer is found to have a tumor larger than 1cm that is triple negative, what treatment should be considered in addition to surgery and radiation?
All triple negative breast cancer with tumor >1cm should consider chemotherapy
Early breast cancer treatment
Surgery + radiation
or
Radical mastectomy if patient fears recurrence
Adjuvant hormone therapy used in breast cancer that prevents conversion of testosterone to estrogen
Aromatase inhibitors
(anastrozole, letrozole, exemestane)
True or false. In stage three breast cancer a modified radical mastectomy is never a necessity
True
Two side effects of tamoxifen
- Thromboembolic disease
- Endometrial cancer
(mostly in women over 50)
How are estrogen positive and estrogen negative metastatic breast cancers treated differently?
Estrogen positive: Hormone therapy
Estrogen negative: Chemo/immunotherapy
Lifestyle changes to prevent breast cancer
- Minimize post-menopausal obesity
- Regular exercise
- Abstinence from alcohol
Name for pre-breast cancer
In situ carcinoma
(most are ductal = DCIS)
Estrogen positive and estrogen negative/HER2 positive breast cancers tend to metastasize to different locations. Where are they?
Estrogen positive: bone metastasis
Estrogen negative/HER2 positive: visceral metastasis
Is the presence of estrogen/progesterone receptors on a breast cancer tumor a good or bad prognostic factor?
Good
- Estrogen/progesterone causes these tumors to grow.
- Hormone therapy can block estrogen and progesterone to stop these tumors from growing.
Methods for diagnosis and staging of breast cancer
Dx: Fine needle aspiration/core-needle biopsy
Staging: MRI both breasts, evaluate lymph nodes, if lymph nodes suspicious then PET scan
Risk factors for breast cancer (many)
- Advancing age, female gender, white
- Post-menopausal obesity
- Reproductive factors: early menarche, late first pregnancy, late menopause, nulliparity
- Environmental: Prolonged use of HRT, consumption of alcohol
- Family history
- Germline mutations (BRCA1 and BRCA2, p53, PTEN)
Tamoxifen alternative with less risk of endometrial cancer
Raloxifene